ArticleHaematologica2024

Simultaneous targeting of B-cell malignancies and human immunodeficiency virus with bispecific chimeric antigen receptor T cells.

Ryan Urak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.